A Single-Dose, Open-Label, Study to Evaluate the Sustainability of the Effects of SYN-010 in Patients With IBS-C
Public ClinicalTrials.gov record NCT02493036. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Single-Dose, Open-Label, Extension Study to Evaluate the Sustainability of the Effects of SYN-010 in Patients With Irritable Bowel Syndrome With Constipation
Study identification
- NCT ID
- NCT02493036
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Theriva Biologics, Inc.
- Industry
- Enrollment
- 54 participants
Conditions and interventions
Interventions
- SYN-010 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2015
- Primary completion
- Nov 30, 2015
- Completion
- Nov 30, 2015
- Last update posted
- Nov 26, 2018
2015
United States locations
- U.S. sites
- 11
- U.S. states
- 2
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Hialeah | Florida | 33012 | — |
| Not listed | Miami | Florida | 33126 | — |
| Not listed | Miami | Florida | 33135 | — |
| Not listed | Miami | Florida | 33165 | — |
| Not listed | Miami Lakes | Florida | 33014 | — |
| Not listed | Miami Springs | Florida | 33166 | — |
| Not listed | St. Petersburg | Florida | 33709 | — |
| Not listed | Tampa | Florida | 33614 | — |
| Not listed | Virginia Gardens | Florida | — | — |
| Not listed | West Palm Beach | Florida | 33409 | — |
| Not listed | New York | New York | 10016-8202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02493036, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 26, 2018 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02493036 live on ClinicalTrials.gov.